Novartis India's Stock Reaches All-Time High, Outperforms Sector and Sensex

Jul 29 2024 01:50 PM IST
share
Share Via
Novartis India, a smallcap pharmaceutical company, has been making headlines in the stock market with its share price reaching an all-time high on July 29, 2024. The stock has gained 7.62% in just three days and is currently trading 2% away from its 52-week high. The company has outperformed the sector and the Sensex, showcasing its strong growth potential.

Novartis India, a smallcap pharmaceutical company, has been making headlines in the stock market as its share price reached an all-time high on July 29, 2024. The stock has been performing well in the past few days, gaining 7.62% in just three days. Today, it opened with a gain of 2.34% and touched an intraday high of Rs 1209, which is 4.58% higher than its previous close.

According to MarketsMOJO, a leading stock market analysis platform, the current stock call for Novartis India is 'Hold'. The company's stock is currently trading 2% away from its 52-week high of Rs 1224. It has also outperformed the sector by 3.58% in today's trading session.

Novartis India's strong performance can also be seen in its moving averages, as it is trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the company's stock.

In comparison to the Sensex, Novartis India has shown a remarkable 1-year performance of 66.35%, while the Sensex has only grown by 23.02% in the same period. This showcases the company's strong growth potential and its ability to outperform the market.

As a smallcap company in the pharmaceutical industry, Novartis India has been able to capture the attention of investors with its consistent growth and strong performance. With its stock reaching an all-time high, it will be interesting to see how the company continues to thrive in the future.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Novartis India falling/rising?
Dec 05 2025 12:56 AM IST
share
Share Via
Why is Novartis India falling/rising?
Nov 06 2025 10:05 PM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 05 2025 08:06 AM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 03 2025 08:04 AM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 02 2025 08:04 AM IST
share
Share Via